Tower Cold Chain, a pharmaceutical thermal protection specialist, opened its new headquarters in Philadelphia, PA.

The 26,000 sq. ft building is designed to strengthen Tower’s container conditioning and storage capabilities, marking a significant milestone in the company’s commitment to pharmaceutical, airline and 3PL customers in North, Central and South America.

Following the success of its Center of Excellence in the UK, Tower Cold Chain has replicated this model, with its latest facility offering design, laboratory, and testing capabilities in the development of its temperature-controlled solutions.

The newly established Americas headquarters also includes office space accessible to customers, offering opportunities for meetings, demonstrations, as well as new product development in partnership with customers.

By establishing a dedicated Center of Excellence in the Americas, Tower Cold Chain aims to strengthen its collaborative partnerships with pharmaceutical manufacturers, airlines, and 3PL providers in the region. The facility will serve as a hub of innovation and expertise, fostering partnerships, knowledge exchange, and the development of customer-focused solutions to address the evolving challenges in the cold chain logistics industry.

“We are thrilled to inaugurate our Center of Excellence in Philadelphia, which demonstrates our unwavering commitment to the Americas market,” said Niall Balfour, CEO of Tower Cold Chain. “This marks a significant step in Tower’s growth trajectory. As demand for robust, reliable, reusable pharmaceutical logistics continues to surge, our investment in strategic locations enables us to provide essential support for the seamless transportation of temperature-sensitive pharmaceutical and life-science products.”